Clinical Study
Testing the drug XEN1101 in adults with epilepsy
This study will test a new study drug called XEN1101 to help patients with epilepsy. Epilepsy is a disease that may occur due to a genetic disorder or brain injury. This condition affects the nerves in the brain causing seizures. The study wants to see if XEN110 will help people with the disease and is safe. People in this study will all receive XEN1101 once a day. The drug is taken as a swallowed pill. Being in the study requires regular clinic visits for about 8 months during participation. Medical tests will be done during the study to track the health of participants.
For more information contact:
Marissa Castillo
marissa.castillo@hsc.utah.edu
8015878393
IRB#: IRB_00164793
| PI: Amir Arain
| Department: NEUROLOGY
| Approval Date: 2023-08-23 06:00:00
Study Categories: Neurological Studies
| Specialties: Neurology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 18 to 75 years old
- Successfully completed Study X-TOLE2, X-TOLE3, or X-ACKT
- Willing to use specific birth control
- Able to attend in person at the University of Utah
Exclusion Criteria:
- Pregnant, breastfeeding, or planning to become pregnant prior to 6 months after the last dose of study drug
- Planning to enter a study with a different study drug or device for the treatment of epilepsy
- Any other medical condition during the study and until 28 days after completing the study
Will I be paid for my time?
Yes